Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Arrowhead Pharmaceuticals
Biotech
Arrowhead on target in lipid disorder as it pursues Ionis
Arrowhead linked its RNAi drug candidate to improved outcomes through Week 48 to stay on Ionis’ tail in the race to market.
Nick Paul Taylor
Apr 8, 2024 9:37am
Arrowhead axes assets, but spares staff, to save $100M a year
Feb 7, 2024 6:01am
Arrowhead finds a new (old) partner for J&J hep B program: GSK
Oct 31, 2023 9:05am
Janssen sticks with Cidara's flu med, but plans to sell it off
Sep 6, 2023 11:39am
Janssen's infectious disease partners left in the lurch
Jul 21, 2023 10:14am
Arrowhead’s $3.7B J&J deal is done, CEO says
Feb 15, 2023 1:12pm